ClinConnect ClinConnect Logo
Search / Trial NCT04739163

Urdu Translation of Duke Activity Status

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Feb 2, 2021

Trial Information

Current as of May 20, 2025

Completed

Keywords

Duke Activity Status Index Heart Diseases Tool Translation

ClinConnect Summary

Literature suggested that Duke Activity Index (DASI) is a questionnaire originally developed in English To evaluate the functionality. DASI was used primarily to assess patients with cardiovascular diseases such as coronary artery disease, heart failure, myocardial ischemia, and infarction. In clinical practice, DASI can be used to know the effects of medical treatments and cardiac rehabilitation and to assist clinical decisions In controlled clinical trials, DASI can also be used to assess interventions and as a component for assessing the costs/benefits of treatment.

Studies demonstrated...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Individuals have enough education level to understand Urdu and English as well with a body mass index between 18.6 and 39.9 kg/m with the diagnosis of cardiovascular diseases such as coronary artery disease, valvular heart disease, arrhythmia with at least one symptom11 such as chest pain, palpitations, fatigue, or dyspnea, and physician referral to exercise testing.
  • Exclusion Criteria:
  • Individual is unable to read the questionnaire, who have cognitive deficits screened by Mini-Mental State Examination according to the cut-off points and Hospitalization two months before as well as acute illness, fever, or severe physical limitation that would prevent from doing the exercise test.

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Sialkot, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Mehwish Waseem, MSPT(CPPT)

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials